AR002011A1 - Compuestos derivados de piperidina, sus sales y n-oxidos, procedimiento de preparacion y composiciones farmaceuticas. - Google Patents

Compuestos derivados de piperidina, sus sales y n-oxidos, procedimiento de preparacion y composiciones farmaceuticas.

Info

Publication number
AR002011A1
AR002011A1 ARP950100629A AR10062995A AR002011A1 AR 002011 A1 AR002011 A1 AR 002011A1 AR P950100629 A ARP950100629 A AR P950100629A AR 10062995 A AR10062995 A AR 10062995A AR 002011 A1 AR002011 A1 AR 002011A1
Authority
AR
Argentina
Prior art keywords
alkyl
hydrogen
alkoxy
piperidine
pharmaceutical compositions
Prior art date
Application number
ARP950100629A
Other languages
English (en)
Inventor
Mary Gaster Laramie
Francis David King
Paul Adrian Wyman
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9426029.6A external-priority patent/GB9426029D0/en
Priority claimed from GBGB9512920.1A external-priority patent/GB9512920D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR002011A1 publication Critical patent/AR002011A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Se describen nuevos derivados de piperidina de fórmula (I), proceso para su preparación, composiciones farmacéuticas que las contienen y su uso comomedicamentos en donde R1 es hidrógeno, halógeno, alquilo, ciclo-alquilo, alquil-CO, alcoxi, hidroxi, hidroxialquilo, hidroxialcoxi, alcoxi-alcoxi,acilo, nitro, trifluorometilo, ciano, SR9, SOR9, SO2R9, SO2NR10R11, CO2R10, NR10SO2R11, CONR10R11, CO2NR10R11, CONR10(CH2)pCO2R11, (CH2)pNR10R11,(CH2)pCONR10R11, (CH2)pNR10COR11, (CH2)pCO2-alquilo, CO2-(CH2)pOR10, CONHNR10R11, NR10R11, NR10CO2R11, NR10CO(CH2)pNR10R11, NR10CONR10R11,CR10=NOR11, CNR10=NOR11, en donde R9, R10 y R11 son independientemente hidrógeno o alquilo y p es 1 a 4; o R1 es un anillo heterocíclico de 5a 7miembros opcionalmente sustituido conteniendo 1 a 4 heteroátomos seleccionados de oxígeno, nitrógeno y azufre; R2 y R3 son hidrógeno, halógeno, alquilo,cicloalquilo, cicloalquenilo, alcoxi, hidroxialquilo, alcoxialquilo, acilo, arilo, aciloxi, hidroxi, nitro, trifluorometilo, ciano, CO2R10, CONR10R11,NR10R11, donde R10 y R11 son hidrógeno o alquilo; R4, R5 y R6 son hidrógeno o alquilo; A es (CR13R14)q donde q es 2, 3 ó 4 y R13 y R14 son hidrógeno oalquilo o A es (CR13R14)r-D, donde r es 0, 1, 2, ó 3 y D es oxígeno, azufre o CR13=CR14, B es oxígeno, CR15R16 o NR17 donde R15, R16 y R17 son hidrógeno oalquilo o B es S(O)b donde b es 0, 1 ó 2; m es 1, 2 ó 3 y n es 1, 2 ó 3.
ARP950100629A 1994-12-22 1995-12-19 Compuestos derivados de piperidina, sus sales y n-oxidos, procedimiento de preparacion y composiciones farmaceuticas. AR002011A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426029.6A GB9426029D0 (en) 1994-12-22 1994-12-22 Novel compounds
GBGB9512920.1A GB9512920D0 (en) 1995-06-24 1995-06-24 Novel compounds

Publications (1)

Publication Number Publication Date
AR002011A1 true AR002011A1 (es) 1998-01-07

Family

ID=26306239

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP950100629A AR002011A1 (es) 1994-12-22 1995-12-19 Compuestos derivados de piperidina, sus sales y n-oxidos, procedimiento de preparacion y composiciones farmaceuticas.

Country Status (27)

Country Link
US (1) US5972951A (es)
EP (1) EP0799226B1 (es)
JP (1) JPH10510821A (es)
CN (1) CN1175256A (es)
AP (1) AP757A (es)
AR (1) AR002011A1 (es)
AT (1) ATE199085T1 (es)
AU (1) AU697361B2 (es)
BG (1) BG61977B1 (es)
BR (1) BR9510419A (es)
CA (1) CA2208244A1 (es)
CZ (1) CZ192397A3 (es)
DE (1) DE69520075T2 (es)
DZ (1) DZ1957A1 (es)
ES (1) ES2153907T3 (es)
FI (1) FI972583A (es)
HU (1) HUT77650A (es)
IL (1) IL116486A0 (es)
MA (1) MA23753A1 (es)
MX (1) MX9704777A (es)
NO (1) NO972910L (es)
NZ (1) NZ298036A (es)
OA (1) OA10610A (es)
PL (1) PL321048A1 (es)
SK (1) SK80297A3 (es)
TR (1) TR199501597A2 (es)
WO (1) WO1996019477A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9519033D0 (en) * 1995-09-18 1995-11-15 Smithkline Beecham Plc Treatment
GB9522845D0 (en) * 1995-11-08 1996-01-10 Smithkline Beecham Plc Novel compounds
US6166034A (en) * 1995-11-08 2000-12-26 Smithkline Beecham P. L. C Spiro piperidine derivatives as 5HT1D receptor antagonists
US5972979A (en) * 1995-11-22 1999-10-26 Smithkline Beecham P.L.C. Tricyclic spiro compounds as 5HT1D receptor antagonists
GB9605883D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Novel compounds
GB9606396D0 (en) * 1996-03-27 1996-06-05 Smithkline Beecham Plc Novel compounds
US6156783A (en) * 1996-04-30 2000-12-05 Smithkline Beecham P.L.C. Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
FR2761069A1 (fr) * 1997-03-20 1998-09-25 Pf Medicament Spiroamines derivees de dihydrobenzofuranes, leur preparation et leur application comme medicaments
CA2347095A1 (en) * 1998-10-16 2000-04-27 Takeda Chemical Industries, Ltd. Nitrogen-containing condensed heterocyclic derivatives, their production and agent
DE10051981A1 (de) 2000-10-20 2002-05-02 Bayer Ag Substituierte Phenyluracile
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
JP5043428B2 (ja) * 2003-06-03 2012-10-10 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ビアリール複素環式化合物ならびにその製造および使用方法
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
JP5304981B2 (ja) 2005-12-26 2013-10-02 日産化学工業株式会社 1,3−ビス(置換フェニル)−3−ヒドロキシプロパン−1−オンおよび2−プロペン−1−オン化合物およびその塩
JP2010524970A (ja) 2007-04-20 2010-07-22 デシフェラ ファーマシューティカルズ,エルエルシー 骨髄増殖性疾患及びその他の増殖性疾患の治療に有用なキナーゼ阻害剤
ES2601856T3 (es) 2007-06-08 2017-02-16 Mannkind Corporation Inhibidores de la IRE-1A
WO2009001942A1 (ja) 2007-06-27 2008-12-31 Nissan Chemical Industries, Ltd. 3-ヒドロキシプロパン-1-オン化合物、2-プロペン-1-オン化合物およびイソキサゾリン化合物の製造方法
PL2350090T3 (pl) 2008-10-17 2015-11-30 Xenon Pharmaceuticals Inc Związki spiro-oksindolowe i ich zastosowanie jako środków terapeutycznych
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
PE20170202A1 (es) 2009-10-14 2017-03-24 Xenon Pharmaceuticals Inc Metodos sinteticos para compuestos espiro-oxoindol
EP2538919B1 (en) 2010-02-26 2017-07-12 Xenon Pharmaceuticals Inc. Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US9682033B2 (en) 2015-02-05 2017-06-20 Teva Pharmaceuticals International Gmbh Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
US11498903B2 (en) 2017-08-17 2022-11-15 Bristol-Myers Squibb Company 2-(1,1′-biphenyl)-1H-benzodimidazole derivatives and related compounds as apelin and APJ agonists for treating cardiovascular diseases
WO2019152711A1 (en) 2018-01-31 2019-08-08 Diciphera Pharmaceuticals Llc. Combination therapy for the treatment of gastrointestinal stromal tumors
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
MX2022001863A (es) 2019-08-12 2022-05-30 Deciphera Pharmaceuticals Llc Metodos para tratar los tumores del estroma gastrointestinal.
WO2021030405A1 (en) 2019-08-12 2021-02-18 Deciphera Pharmaceuticals, Llc Ripretinib for treating gastrointestinal stromal tumors
IL293864A (en) 2019-12-30 2022-08-01 Deciphera Pharmaceuticals Llc Preparations of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3- phenylurea
HRP20231699T1 (hr) 2019-12-30 2024-05-10 Deciphera Pharmaceuticals, Llc Formulacije inhibitora amorfne kinaze i postupci njihove primjene
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0533268T3 (da) 1991-09-18 2001-12-03 Glaxo Group Ltd Benzanilidderivater som 5HT-1D antagonister
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
AP9701006A0 (en) 1997-07-31
AP757A (en) 1999-09-06
CZ192397A3 (en) 1997-09-17
EP0799226A1 (en) 1997-10-08
CN1175256A (zh) 1998-03-04
SK80297A3 (en) 1998-12-02
AU4343396A (en) 1996-07-10
FI972583A0 (fi) 1997-06-17
BG101715A (en) 1998-02-27
NZ298036A (en) 1998-11-25
ES2153907T3 (es) 2001-03-16
MX9704777A (es) 1997-10-31
MA23753A1 (fr) 1996-07-01
PL321048A1 (en) 1997-11-24
NO972910L (no) 1997-08-14
IL116486A0 (en) 1997-08-14
BR9510419A (pt) 1998-05-19
US5972951A (en) 1999-10-26
ATE199085T1 (de) 2001-02-15
BG61977B1 (bg) 1998-11-30
OA10610A (en) 2002-09-06
CA2208244A1 (en) 1996-06-27
WO1996019477A1 (en) 1996-06-27
EP0799226B1 (en) 2001-02-07
DZ1957A1 (fr) 2002-02-17
AU697361B2 (en) 1998-10-01
NO972910D0 (no) 1997-06-20
FI972583A (fi) 1997-08-19
TR199501597A2 (tr) 1996-07-21
JPH10510821A (ja) 1998-10-20
DE69520075D1 (de) 2001-03-15
HUT77650A (hu) 1998-07-28
DE69520075T2 (de) 2001-08-02

Similar Documents

Publication Publication Date Title
AR002011A1 (es) Compuestos derivados de piperidina, sus sales y n-oxidos, procedimiento de preparacion y composiciones farmaceuticas.
ZA984640B (en) 9-Azabicyclo[3.3.1]non-2-ene and nonane derivatives their preparations and use
AR004516A1 (es) Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen
IE891797L (en) 4-amino quinolines and naphthyridines, process for their¹preparation and their use as medicines
BG104287A (en) Halogensubstituted tetracyclic derivatives of tetrahydrofuran
ATE182889T1 (de) Bicyclische amidinderivate als no-synthetase inhibitoren
AR008291A1 (es) Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento.
IE862630L (en) 3-VINYL AND 3-ETHYNYL-ß-CARBOLINES
KR880001650A (ko) 트리아졸로피리딘 또는 트리아졸로퀴놀린의 신규 아미노알킬티오 유도체, 그의 제조방법 및 특히 진통제로서 유용한 그것이 존재하는 약제
DE69526917D1 (de) Anthracyclinon-derivate und ihre verwendung in amyloidose
ATE199543T1 (de) Bibphenylamid-derivate als 5-ht1d-antagonisten
DK1034174T3 (da) Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer
ES476863A1 (es) Un procedimiento para la preparacion de nuevos derivados de anilina.
ATA49688A (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
PT90912A (pt) Processo para a preparacao de derivados de tiofenol
DE69810107D1 (de) Azacyclooktan- und heptan-derivate, ihre herstellung und ihre therapeutische verwendung
NZ218453A (en) Pharmaceutical compositions containing a synergistic mixture of a dihydropyridine derivative and pyridazodiazepine derivative
SE7503868L (sv) Forfarande for framstellning av bensobicyklonenderivat.
ES2099727T3 (es) 8-azabiciclo(3.2.1)octilalquiltiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos.
AU547599B2 (en) Tricyclic compounds
CO4700296A1 (es) Compuestos nuevos para el tratamiento de desordenes del snc y el proceso para su preparacion
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE68903893D1 (de) 20,21-dinoreburnamenin-derivate, substituiert in position 15 durch eine aminogruppe und deren salze, verfahren zu deren herstellung und die auf diese weise erhaltenen zwischenverbindungen, deren anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen.
CO4920231A1 (es) Nuevos compuestos produccion y su aplicacion como medicamentos
ATE138068T1 (de) 1,2,4-triazolo(1,5-a>pyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung